|
1)
Rodney A. Appell, M.D., Director, Texas Continence
Center, Vanguard Urologic Institute, clinical Professor of Urology,
Baylor College of Medicine will be speaking on "Non-surgical
Minimally Invasive Treatment for Stress Incontinence"
during the Incontinence/Pelvic Floor session on Tuesday, October
28. (This will be a non-cme talk).
2) Irwin Goldstein, M.D., Director of San Diego
Sexual Medicine at Alavarado Hospital will present "Controversies
in Sexual Medicine" during the Sexual Medicine
session on Tuesday, October 28.
3)
Badrinath Konety, M.D., Vice Chairman, Department
of Urology, University of California, San Francisco, will speak
on "Evidence-Based Medicine"
on Tuesday afternoon.
4)
Antoine Khoury, M.D., Chief of Pediatric Urology
at UC Irvine Medical Center & Children’s Hospital of Orange
County will speak on "Prophylactic Antibiotics
for Vesicoureteral Reflux" during the Pediatrics
session on Tuesday, October 28.
5)
Timothy Wilson, M.D., Director, Urology and Urologic
Oncology at City of Hope Cancer Center will present "Robotic
cystectomy with extended lymphadenectomy" during
the Bladder/Urethra session on Tuesday, October 28.
6)
Margaret S. Pearle, M.D., Ph.D., Professor of Urology
and Internal Medicine The University of Texas will present "Urolithiasis:
Metabolic Evaluation and Medical Treatment" during
the Calculi session on Wednesday, October 29.
7)
Colin Colins, Ph.D., Associate Professor of Urology,
UC San Francisco will speak on "Genomic Biomarkers
for Risk Stratification" during the Prostate
1 session on Wednesday, October 29.
8)
Erik Castle, M.D., Associate Professor of Urology,
Mayo Clinic-Scottsdale, Arizona, will present "Robot
Assisted Radical Cystectomy: Is it ready for Prime Time"
during the Kidney/Laparoscopy Session on Wednesday, October 29.
9)
Bryan Donnelly, M.D., Assistant Professor of Urology,
University of Calgary in Canada, will speak on "Role
of Cryotherapy in Localized Prostate Cancer"
during the Prostate 2 Session on Thursday, October 30.
10)
Christopher Evans, M.D., Professor and Chairman,
Department of Urology, Urologic Surgical Oncology, University of
California, Davis, School of Medicine will speak on "Targeted
Therapies in Prostate and Renal Cancers" during
the Prostate 2 session on Thursday, October 30.
|